Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

Let's look at why this news could be a game-changer for Eli Lilly and its stock.

A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.

After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...

People with type 2 diabetes taking the highest dose of Eli Lilly’s experimental drug orfoglipron lowered their blood sugar and lost 16 pounds on average after 40 weeks.

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Medications like Ozempic and Zepbound work to mimic GLP-1, a hormone that makes you feel full. But there are also ways to ...

"Injections cannot be the solution for billions of people around the world." Doctors believe that GLP-1 agonists work by binding to receptors that tell your body to release the hormone GLP-1 ...

Lexaria Bioscience (LEXX) provides a glucagon-like peptide-1 strategic update following important industry developments reported both by Pfizer ...

GLP-1 receptor agonists such as semaglutide and tirzepatide have proven to be highly effective in supporting weight loss by regulating appetite and metabolism. These medications work by mimicking ...

Most GLP-1 drugs used for weight loss, such as Mounjaro and Zepbound as well as Novo Nordisk's Ozempic and Wegovy, are administered by injection. Novo Nordisk does have an FDA-approved oral GLP-1 ...